224 publications
Name | Date | Type | Actions |
---|---|---|---|
2024 half-year Results Sales: €264m (+3.2% as reported) |
Public releases | ||
Buyback programs - August 2024 Monthly communication regarding buyback programs |
Description of buyback programs | ||
Buyback programs - July 2024 Monthly communication regarding buyback programs |
Description of buyback programs | ||
Buyback programs - June Monthly communication regarding buyback programs |
Description of buyback programs | ||
SALES 1st quarter 2024: €134M The Vetoquinol Group recorded sales of €133.7 million in the 1st quarter of fiscal 2024, including €83.4 million for Essential products. |
Public releases | ||
Availability of the 2023 universal registration document On 24 April 2024, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format). |
Public releases | ||
Buyback programs - March 2024 Monthly communication regarding buyback programs |
Description of buyback programs | ||
2023 ANNUAL RESULTS Annual sales: €529m (stable at constant exchange rates) |
Public releases | ||
Buyback programs – January 2024 Monthly communication regarding buyback programs |
Description of buyback programs | ||
Annual sales 2023: €529 million Annual Sales of Essential products: €313 million (up 4.5% at constant exchange rates) |
Public releases |